Inebilizumab -cdon, a monoclonal antibody that depletes B cells, reduces the risk for flares without showing any new safety ...

BE-101 is an autologous B-cell treatment. This means the B-cells that are used as part of BE-101 are collected from the ...

Dormant Epstein-Barr virus (EBV) becomes activated and triggers inflammation during MS disease activity, a study suggests.

In the United States, Graves’ disease accounts for up to 80% of all hyperthyroid cases. Antibodies are proteins produced by B cells that are meant to neutralize and destroy foreign invaders, such as ...

Scientists should focus on the interactions between T and B cells to find better treatments for autoimmune disorders, such as ...

NKT cell activators hold promise for potential systemic lupus erythematosus (SLE) treatment, preclinical data show.

Germline-targeting epitope scaffold nanoparticles elicit rare broadly neutralizing antibody (bnAb) precursors against human ...

Results from NIH-funded animal models will inform the development of vaccines for humans. Using advanced immunological ...

Using a combination of cutting-edge immunologic technologies, researchers have successfully stimulated animals' immune systems to induce rare precursor B cells of a class of HIV broadly neutralizing ...

Novel Vaccine Concept Generates Immune Responses that NIH Says Could Produce Multiple Types of HIV Broadly Neutralizing ...

A novel CAR T-cell therapy designed to target two cell types led to SLE remission in a small Phase 1 clinical trial with ...

Using a combination of cutting-edge immunologic technologies, researchers have successfully stimulated animals' immune systems to induce rare precursor B cells of a class of HIV broadly neutralizing ...